Medication and Care Strategies

While a diagnosis of PRKN-related Parkinson’s disease (PRKN-PD) requires a long-term management plan, the outlook for medication response is generally very favorable. Most people with this genetic form of the disease experience a “robust” and “excellent” response to standard therapy, often allowing for high levels of function ^[1][2].

The Gold Standard: Levodopa

Levodopa remains the most effective treatment for managing the motor symptoms of PRKN-PD ^[3]. There is a common misconception that levodopa should be delayed as long as possible to “save it” for later or to avoid side effects. However, current clinical wisdom suggests that you should not delay levodopa solely out of fear of future complications, as undertreated symptoms can severely impact your mobility ^[4].

• Sensitivity: People with PRKN-PD are often very sensitive to levodopa, meaning even low-to-moderate doses can provide significant relief from stiffness and slowness ^[1].
• Sustained Benefit: The motor benefit from levodopa in people with biallelic PRKN mutations often remains robust for a long period, though doses will need periodic adjustment ^[1].

Navigating Motor Complications

Over time, as the disease progresses and you have taken medication for years, you may encounter two main types of motor complications:

1. Wearing-off: This occurs when a dose of medication begins to lose its effect before it is time for the next dose, causing symptoms like foot cramping (dystonia) or slowness to return ^[5].
2. Dyskinesia: These are involuntary, often flowing or “wiggling” movements that typically happen when the level of levodopa in your brain is at its peak ^[6].

While these complications are sometimes described as developing later on average in PRKN-PD compared to other early-onset types, young-onset patients have a long lifetime of treatment exposure. Because of this, wearing-off and dyskinesia do occur and can sometimes develop relatively early ^[1]. If they become bothersome, your doctor has several strategies:

• Fractionation: Taking smaller doses of levodopa more frequently throughout the day to keep brain levels steady ^[7].
• Enzyme Inhibitors: Adding medications like MAO-B inhibitors or COMT inhibitors that prevent the body from breaking down dopamine, effectively “stretching” the life of each levodopa dose ^[8]. Be aware of possible side effects like hallucinations or worsening dyskinesia.
• Amantadine: This medication can be added specifically to reduce the severity of dyskinesia ^[9].

Important Caution: Dopamine Agonists and Behavior

Dopamine agonists (such as pramipexole or ropinirole) are another class of medication sometimes used to treat Parkinson’s. While they can be effective, they carry a significantly higher risk of Impulse Control Disorders (ICDs) compared to levodopa ^[10].

ICDs are serious behavioral side effects where a person feels an uncontrollable urge to engage in rewarding but potentially harmful activities ^[11]. These can include:

• Compulsive gambling or shopping.
• Binge eating.
• Hypersexuality (an intense or preoccupying interest in sex).
• Punding: Repetitive, purposeless tasks like sorting buttons or dismantling electronics ^[12].

Because younger patients are generally at higher risk for these behaviors, extra caution is mandatory ^[13]. Your care team should screen you and your family for these behaviors at every visit ^[14].

CRITICAL SAFETY WARNING: DO NOT STOP ABRUPTLY
If an ICD develops, or if you experience severe side effects, the dopamine agonist must be reduced or stopped under close medical supervision. Do NOT stop taking these medications abruptly on your own. Sudden cessation can cause Dopamine Agonist Withdrawal Syndrome (DAWS)—a severe condition causing panic attacks, depression, and profound worsening of parkinsonism ^[15].

When to Contact Your Clinician Promptly:

• New compulsive behaviors (shopping, gambling, eating, sexual behavior).
• Hallucinations or severe confusion.
• Sudden “sleep attacks” (falling asleep without warning during the day, which is especially dangerous if driving).
• Fainting or severe dizziness when standing (orthostatic hypotension).
• Abrupt loss of medication benefit.